Cargando…
Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation
AIMS : Dilated cardiomyopathy (DCM) is associated with mutations in many genes encoding sarcomere proteins. Truncating mutations in the titin gene TTN are the most frequent. Proteomic and functional characterizations are required to elucidate the origin of the disease and the pathogenic mechanisms o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752363/ https://www.ncbi.nlm.nih.gov/pubmed/33135063 http://dx.doi.org/10.1093/cvr/cvaa316 |
_version_ | 1784631872457801728 |
---|---|
author | Vikhorev, Petr G Vikhoreva, Natalia N Yeung, WaiChun Li, Amy Lal, Sean dos Remedios, Cristobal G Blair, Cheavar A Guglin, Maya Campbell, Kenneth S Yacoub, Magdi H de Tombe, Pieter Marston, Steven B |
author_facet | Vikhorev, Petr G Vikhoreva, Natalia N Yeung, WaiChun Li, Amy Lal, Sean dos Remedios, Cristobal G Blair, Cheavar A Guglin, Maya Campbell, Kenneth S Yacoub, Magdi H de Tombe, Pieter Marston, Steven B |
author_sort | Vikhorev, Petr G |
collection | PubMed |
description | AIMS : Dilated cardiomyopathy (DCM) is associated with mutations in many genes encoding sarcomere proteins. Truncating mutations in the titin gene TTN are the most frequent. Proteomic and functional characterizations are required to elucidate the origin of the disease and the pathogenic mechanisms of TTN-truncating variants. METHODS AND RESULTS : We isolated myofibrils from DCM hearts carrying truncating TTN mutations and measured the Ca(2+) sensitivity of force and its length dependence. Simultaneous measurement of force and adenosine triphosphate (ATP) consumption in skinned cardiomyocytes was also performed. Phosphorylation levels of troponin I (TnI) and myosin binding protein-C (MyBP-C) were manipulated using protein kinase A and λ phosphatase. mRNA sequencing was employed to overview gene expression profiles. We found that Ca(2+) sensitivity of myofibrils carrying TTN mutations was significantly higher than in myofibrils from donor hearts. The length dependence of the Ca(2+) sensitivity was absent in DCM myofibrils with TTN-truncating variants. No significant difference was found in the expression level of TTN mRNA between the DCM and donor groups. TTN exon usage and splicing were also similar. However, we identified down-regulation of genes encoding Z-disk proteins, while the atrial-specific regulatory myosin light chain gene, MYL7, was up-regulated in DCM patients with TTN-truncating variants. CONCLUSION : Titin-truncating mutations lead to decreased length-dependent activation and increased elasticity of myofibrils. Phosphorylation levels of TnI and MyBP-C seen in the left ventricles are essential for the length-dependent changes in Ca(2+) sensitivity in healthy donors, but they are reduced in DCM patients with TTN-truncating variants. A decrease in expression of Z-disk proteins may explain the observed decrease in myofibril passive stiffness and length-dependent activation. |
format | Online Article Text |
id | pubmed-8752363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87523632022-01-12 Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation Vikhorev, Petr G Vikhoreva, Natalia N Yeung, WaiChun Li, Amy Lal, Sean dos Remedios, Cristobal G Blair, Cheavar A Guglin, Maya Campbell, Kenneth S Yacoub, Magdi H de Tombe, Pieter Marston, Steven B Cardiovasc Res Original Articles AIMS : Dilated cardiomyopathy (DCM) is associated with mutations in many genes encoding sarcomere proteins. Truncating mutations in the titin gene TTN are the most frequent. Proteomic and functional characterizations are required to elucidate the origin of the disease and the pathogenic mechanisms of TTN-truncating variants. METHODS AND RESULTS : We isolated myofibrils from DCM hearts carrying truncating TTN mutations and measured the Ca(2+) sensitivity of force and its length dependence. Simultaneous measurement of force and adenosine triphosphate (ATP) consumption in skinned cardiomyocytes was also performed. Phosphorylation levels of troponin I (TnI) and myosin binding protein-C (MyBP-C) were manipulated using protein kinase A and λ phosphatase. mRNA sequencing was employed to overview gene expression profiles. We found that Ca(2+) sensitivity of myofibrils carrying TTN mutations was significantly higher than in myofibrils from donor hearts. The length dependence of the Ca(2+) sensitivity was absent in DCM myofibrils with TTN-truncating variants. No significant difference was found in the expression level of TTN mRNA between the DCM and donor groups. TTN exon usage and splicing were also similar. However, we identified down-regulation of genes encoding Z-disk proteins, while the atrial-specific regulatory myosin light chain gene, MYL7, was up-regulated in DCM patients with TTN-truncating variants. CONCLUSION : Titin-truncating mutations lead to decreased length-dependent activation and increased elasticity of myofibrils. Phosphorylation levels of TnI and MyBP-C seen in the left ventricles are essential for the length-dependent changes in Ca(2+) sensitivity in healthy donors, but they are reduced in DCM patients with TTN-truncating variants. A decrease in expression of Z-disk proteins may explain the observed decrease in myofibril passive stiffness and length-dependent activation. Oxford University Press 2020-11-02 /pmc/articles/PMC8752363/ /pubmed/33135063 http://dx.doi.org/10.1093/cvr/cvaa316 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Vikhorev, Petr G Vikhoreva, Natalia N Yeung, WaiChun Li, Amy Lal, Sean dos Remedios, Cristobal G Blair, Cheavar A Guglin, Maya Campbell, Kenneth S Yacoub, Magdi H de Tombe, Pieter Marston, Steven B Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title | Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title_full | Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title_fullStr | Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title_full_unstemmed | Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title_short | Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
title_sort | titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752363/ https://www.ncbi.nlm.nih.gov/pubmed/33135063 http://dx.doi.org/10.1093/cvr/cvaa316 |
work_keys_str_mv | AT vikhorevpetrg titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT vikhorevanatalian titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT yeungwaichun titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT liamy titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT lalsean titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT dosremedioscristobalg titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT blaircheavara titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT guglinmaya titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT campbellkenneths titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT yacoubmagdih titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT detombepieter titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation AT marstonstevenb titintruncatingmutationsassociatedwithdilatedcardiomyopathyalterlengthdependentactivationanditsmodulationviaphosphorylation |